Trung C. Pham

973 total citations
11 papers, 769 citations indexed

About

Trung C. Pham is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Trung C. Pham has authored 11 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Trung C. Pham's work include Estrogen and related hormone effects (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Trung C. Pham is often cited by papers focused on Estrogen and related hormone effects (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Trung C. Pham collaborates with scholars based in United States, Austria and Japan. Trung C. Pham's co-authors include Giuseppe Giaccone, Shailaja D. Divekar, Adriana Stoica, Johanna E Camara, K. Pratap, Ronald Reiter, Mary Beth Martin, Yaniris R. Avellanet, Iacopo Petrini and Johannes Voortman and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Trung C. Pham

10 papers receiving 752 citations

Peers

Trung C. Pham
Daniel N. Johnson United States
Trung C. Pham
Citations per year, relative to Trung C. Pham Trung C. Pham (= 1×) peers Daniel N. Johnson

Countries citing papers authored by Trung C. Pham

Since Specialization
Citations

This map shows the geographic impact of Trung C. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trung C. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trung C. Pham more than expected).

Fields of papers citing papers by Trung C. Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trung C. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trung C. Pham. The network helps show where Trung C. Pham may publish in the future.

Co-authorship network of co-authors of Trung C. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Trung C. Pham. A scholar is included among the top collaborators of Trung C. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trung C. Pham. Trung C. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Turgeon, D. Kim, Julia Luther, Patrick Becker, et al.. (2024). A novel, noninvasive, multimodal screening test for the early detection of precancerous lesions and colorectal cancers using an artificial intelligence–based algorithm.. Journal of Clinical Oncology. 42(16_suppl). 3627–3627.
2.
Wang, Yisong, Anish Thomas, Christopher Lau, et al.. (2014). Mutations of epigenetic regulatory genes are common in thymic carcinomas. Scientific Reports. 4(1). 98 indexed citations
3.
Raffeld, Mark, Yong Wha Moon, Liqiang Xi, et al.. (2014). CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance. Journal of Clinical Investigation. 124(7). 3003–3015. 83 indexed citations
4.
Petrini, Iacopo, Arun Rajan, Trung C. Pham, et al.. (2013). Whole Genome and Transcriptome Sequencing of a B3 Thymoma. PLoS ONE. 8(4). e60572–e60572. 25 indexed citations
5.
Park, Kang‐Seo, Giuseppe Giaccone, Yisong Wang, et al.. (2013). Abstract 4468: Cripto-1 elicits innate resistance to EGFR inhibitors in non-small cell lung cancer harboring EGFR-sensitizing mutations.. Cancer Research. 73(8_Supplement). 4468–4468. 1 indexed citations
6.
Lee, Jih‐Hsiang, Johannes Voortman, Anne‐Marie C. Dingemans, et al.. (2011). MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer. PLoS ONE. 6(6). e21300–e21300. 66 indexed citations
7.
Voortman, Johannes, Akiteru Goto, Jean Mendiboure, et al.. (2010). MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma. Cancer Research. 70(21). 8288–8298. 109 indexed citations
8.
Attardi, Barbara, Sheri Ann Hild, Sailaja Koduri, et al.. (2010). The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects. The Journal of Steroid Biochemistry and Molecular Biology. 122(4). 212–218. 24 indexed citations
9.
Voortman, Johannes, Akiteru Goto, Jean Mendiboure, et al.. (2010). Abstract 2995: MicroRNA expression and outcome of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program (IALT-Bio). Cancer Research. 70(8_Supplement). 2995–2995. 1 indexed citations
10.
Attardi, Barbara, et al.. (2008). Dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase. The Journal of Steroid Biochemistry and Molecular Biology. 110(3-5). 214–222. 29 indexed citations
11.
Martin, Mary Beth, Ronald Reiter, Trung C. Pham, et al.. (2003). Estrogen-Like Activity of Metals in Mcf-7 Breast Cancer Cells. Endocrinology. 144(6). 2425–2436. 333 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026